This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital, Boston, Massachusetts
  2. Corresponding author: Rachel Vanderkruik, PhD, MSc, Massachusetts General Hospital, 185 Cambridge St, Boston, MA 02114 ([email protected]).
  3. Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital, Boston, Massachusetts
  4. Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital, Boston, Massachusetts
  5. Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital, Boston, Massachusetts
  6. Renée Crown Wellness Institute, University of Colorado Boulder, Boulder, Colorado
  7. Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital, Boston, Massachusetts
  1. Cai H, Xie X-M, Zhang Q, et al. Prevalence of suicidality in major depressive disorder: a systematic review and meta-analysis of comparative studies. Front Psychiatry. 2021;12:690130. PubMed CrossRef
  2. Ballard ED, Snider SL, Nugent AC, et al. Active suicidal ideation during clinical antidepressant trials. Psychiatry Res. 2017;257:303–308. PubMed CrossRef
  3. Courtet P, Nobile B. Inclusion of suicidal individuals in research studies. J Clin Psychiatry. 2020;81(3):20com13276. PubMed CrossRef
  4. Iltis AS, McCall WV, Deria R. Suicidality, depression, and the FDA: health inequities and the ethical conduct of research. J Clin Psychiatry. 2020;81(2):19m13050. PubMed CrossRef
  5. Bentley KH, Maimone JS, Kilbury EN, et al. Practices for monitoring and responding to incoming data on self-injurious thoughts and behaviors in intensive longitudinal studies: A systematic review. Clin Psychol Rev. 2021;90:102098. PubMed CrossRef
  6. Schatten HT, Gaudiano BA, Primack JM, et al. Monitoring, assessing, and responding to suicide risk in clinical research. J Abnorm Psychol. 2020;129(1):64–69. PubMed CrossRef
  7. Ali J, Morain SR, O’Rourke PP, et al. Responding to signals of mental and behavioral health risk in pragmatic clinical trials: ethical obligations in a healthcare ecosystem. Contemp Clin Trials. 2022;113:106651. PubMed CrossRef
  8. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. PubMed CrossRef
  9. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266–1277. PubMed CrossRef
  10. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288. PubMed CrossRef
  11. Motto JA, Bostrom AG. A randomized controlled trial of postcrisis suicide prevention. Psychiatr Serv. 2001;52(6):828–833. PubMed CrossRef